Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT05578495
Recruiting Not applicable

Association of a Digital Signature of Physical Activity and Sedentary Lifestyle With the Development of Multimorbidities in Chronic Diseases (eMOB)

NCT05578495 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Clermont-Ferrand
Phase
Not applicable
Started
2023-12-07
Last updated
2025-09-24

Condition(s) studied

ExerciseSedentary BehaviorNon Communicable DiseasesComorbidities and Coexisting ConditionsComorbidityMultimorbidityDigital Technology

Investigational drug(s) / intervention(s)

Accelerometer data

Accelerometer data: Patients will wear an accelerometer 3 times a year for 5 days (3 weekdays and 2 weekend days), the data will be collected

Study summary

Physical activity (PA) and sedentary lifestyle are determinants in the development of chronic diseases and associated quality of life alterations. PA levels are correlated with quality of life and morbidity in chronic lung disease (COPD), cardiovascular disease, diabetes, cancer, chronic inflammatory rheumatism, fibromyalgia and anxiety disorders. In these diseases, low-intensity PA often represents the main PA and the quantity of PA is correlated with health parameters.

This study aims to identify a typical profile (signature) in relation to the appearance of other chronic diseases, complications of your disease, from recording your physical activity and sedentary lifestyle by sensors evaluating very precisely the movements and taking into account the characteristics and disability related to your disease. The results of this study would therefore make it possible to identify this signature even before the appearance of complications or other diseases.

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * Patient follow-up at CHU Clermont-Ferrand for a chronic disease in one of the following observational cohorts: * Inflammatory rheumatic disease(rheumatoid arthritis, spondyloarthritis) included in the RCVRIC cohort (CPP Sud-Est VI N° ID-RCB- A01847-40) * Pre-surgical knee and hip osteoarthritis (Evalmob) (ID-RCB N° 2019- A01017-50) * Major depressive disorder included in the FACE-DR cohort (CNIL agreement: DR- 2015-673) and Bipolar disorder included in the FACE-BD cohort (CPP Ile de France IX; January 18, 2010) of the Adult Psychiatry Department B * Type 2 diabetes included in the cohort of the sport medicine service "Rehabilitation T2" (CNIL agreement 0164) * Obesity included in the "Obesity" sports medicine service cohort (CNIL agreement 0164) * COPD included in the "COPD Rehabilitation" sports medicine service cohort (CNIL agreement 0164) * Chronic pain cohort (eDOL) (CPP West II N° ID-RCB 2020-A02027-32) * Affiliation to a social security system. * Able to provide written informed consent to participate in the research. Exclusion Criteria: * Inability to practice physical activity * Pregnant or breastfeeding * Refusal to participate * Minors or adults under the protection of the law or under the protection of justice.

Primary outcome measure(s)

  • Occurrence of one additional comorbidity in patients with chronic diseases. — year 4
    Association of a digital signature of PA and sedentary lifestyle with the development of at least one additional comorbidity over 4 years of follow-up.
  • Digital signature of sedentary lifestyle and PA in patients with chronic diseases. — Year 4
    A sensor of movement will be worn by the patients for 5 days every 4 months during the study, to detect and quantify the physical activity and the sedentarity according to their intensity. This sensor will be accelerometer, allowing the acquisition of movements second by second. The analysis of the data from the sensors, the occurrence of a new comorbidity, the clinical data will allow to establish an algorithm to define a profile (digital signature) of occurrence of a new chronic disease.

Trial sites (1)

FacilityCityRegionStatus
CHU de Clermont-Ferrand Clermont-Ferrand France Recruiting

More University Hospital, Clermont-Ferrand trials in France

Resting-state Imaging and Chronic Consumption of Non-Nutritive SweetenerS Starting soon
Childhood Obesity Risk Markers (MARIOBE) Starting soon
Cohort of Chronic Pain Patients Recruiting
Efficacy of Orosol® in the Treatment of Chemo- and Radiation-induced Mucositis. Recruiting
Evaluation of Masticatory Performance in Patients With Periodontitis Recruiting

Other trials for the same condition

Acute Cardiac Effects of Ultra-Trail Running Starting soon
Acute Effect of Polyphenols Supplementation on Endothelial Function and Exercise Related Markers, in Physically Active Healthy Volunteers. Active, not recruiting
Exercise-snacks for Breaking the Sedentary Lifestyle and Improving the Physical Fitness of Obese Adolescents? Recruiting
Methodological Study of Exercise and Hypoxic Conditions in Healthy Subjects Starting soon
The NutriNet-Santé Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05578495 on ClinicalTrials.gov ↗ ← All trials in France